clottriever thrombectormy system clottriever catheter clottriever sheath

The ClotTriever Thrombectomy System is a mechanical thrombectomy device designed for the removal of thrombi from the venous system. It is intended for use in patients with deep vein thrombosis (DVT) to restore venous flow and reduce thrombus burden.

The device is commonly used in clinical settings for the treatment of iliofemoral deep vein thrombosis, especially in cases where anticoagulation is insufficient or contraindicated. It is also utilized in scenarios requiring rapid thrombus removal to prevent complications such as post-thrombotic syndrome.

The available literature includes 10 studies, comprising randomized controlled trials, retrospective analyses, and case series, published between 2023 and 2024. These studies evaluate the device's efficacy and safety in treating venous thromboembolic conditions.

Published studies report that the ClotTriever Thrombectomy System effectively reduces thrombus burden and improves venous patency in patients with deep vein thrombosis. Some studies highlight its superiority over anticoagulation alone in preventing post-thrombotic syndrome. The device has shown promising results in maintaining catheter patency and reducing restenosis risk.

Reported complications include bleeding risks associated with the procedure, although these are generally lower compared to thrombolytic therapies. Some studies note minor procedural complications, but overall, the device is considered safe for clinical use.

Current evidence is limited by the small sample sizes and the retrospective nature of some studies. Further research is needed to establish long-term outcomes and compare the device's efficacy against other thrombectomy systems.